✦ LIBER ✦

Pharmacokinetics of nitroglycerin and its four metabolites during nitroglycerin transdermal administration

✍ Scribed by Chao Han; Paul Jung; Steven W. Sanders; Emil T. Lin; Leslie Z. Benet

Publisher: John Wiley and Sons
Year: 1994
Tongue: English
Weight: 249 KB
Volume: 15
Category: Article
ISSN: 0142-2782
DOI: 10.1002/bdd.2510150210

No coin nor oath required. For personal study only.

✦ Synopsis

Six healthy, adult male volunteers, weighing 70-90 kg, received each of two transdermal patches, applied to the chest, in a randomized crossover two-period

📜 SIMILAR VOLUMES

Pharmacokinetics of nitroglycerin and me

Pharmacokinetics of nitroglycerin and metabolites in humans following oral dosing

✍ Dale K. Yu; Dennis H. Giesing; Roger L. Williams; Leslie Z. Benet; Emil T. Lin 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 401 KB

Integrated pharmacokinetic and metabolic

Integrated pharmacokinetic and metabolic modeling of selegiline and metabolites after transdermal administration

✍ Shashank Rohatagi; Jeffrey S. Barrett; Kimberly E. Dewitt; Richard J. Morales 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 249 KB 👁 1 views

Selegiline (SEL) is a selective, irreversible inhibitor of MAO-B, used in the treatment of Parkinson's disease, either alone or as an adjunct to L-DOPA. Selegiline hydrochloride (HCl) undergoes significant first-pass metabolism following oral administration. Transdermal delivery avoids the first-pas

Pharmacokinetics of stobadin and of the

Pharmacokinetics of stobadin and of the sum of its metabolites in rats during repeated administration

✍ Zoltán Kállay; Ladislav Šoltés; Tomáš Trnovec 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB 👁 1 views

Stobadin dihydrochloride was administered p.0. to rats at a dose of lmg kg-' once daily for 25 consecutive days. The peak and trough concentrations of the sum of stobadin metabolites, determined from Days 6 1 6 of treatment, demonstrated a steady-state. The mean daily excretion of 'H-radioactivity d

Pharmacokinetic studies of the nitroglyc

Pharmacokinetic studies of the nitroglycerin metabolites, 1,2- and 1,3- glyceryl dinitrates, in the rat

✍ David T.-W. Lau; Mark Gumbleton; Christoph Labisch; Leslie Z. Benet 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 393 KB 👁 1 views

1,2-and 1,3-glyceryl dinitrates (1,2-GDN and 1,3-GDN) are the primary metabolites of glyceryl trinitrate, a commonly used anti-anginal agent. The goal of this study was to examine the pharmacokinetic properties of these metabolites in rats. Sprague-Dawley rats were infused intravenously with 0.25 or

Pharmacokinetics of desethylamiodarone i

Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone

✍ Anooshirvan Shayeganpour; Dalia A. Hamdy; Dion R. Brocks 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 1 views

## Abstract The pharmacokinetics of desethylamiodarone (DEA), the active metabolite of amiodarone (AM), were studied in the rat after administration of AM or preformed metabolite. Rats received 10 mg/kg of either intravenous or oral AM HCl or DEA base. Blood samples were obtained via a surgically i

Pharmacokinetics of sulfluramid and its

Pharmacokinetics of sulfluramid and its metabolite desethylsulfluramid after intravenous and intraruminal administration of sulfluramid to sheep

✍ Vitayavirasuk, Banjong; Bowen, John M 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 2 views

Pharmacokinetic properties and tissue residues of the insecticide sul¯uramid (I) and its major metabolite desethylsul¯uramid (II) were determined in healthy sheep after bolus intravenous (IV) administration (5 and 15 mg kg À1 ; n = 10) and bolus intraruminal (IR) administration (100 and 400 mg kg À1